Oppenheimer & Co’s Steris STE Stock Holding History

Oppenheimer & Co’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-974	Closed	-$215K	–	1833
2026 Q1	$215K	Hold	974	–	–	﹤0.01%	1544
2025 Q4	$247K	Buy	+974	New	+$245K	﹤0.01%	1350
2019 Q4	–	Sell	-2,032	Closed	-$294K	–	1317
2019 Q3	$294K	Sell	2,032 -20	-1%	-$2.99K	0.01%	987
2019 Q2	$306K	Buy	+2,052	New	+$274K	0.01%	998

Other funds holding STE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Oppenheimer & Co's STE Position: Q2 2026 in Review

Oppenheimer & Co sold out of Steris (STE) in Q2 2026, closing a stake of 974 shares — an estimated $215K sold.

Oppenheimer & Co first reported a position in STE in Q2 2019 and held it in 4 quarters. The position peaked at $306K in Q2 2019. 837 funds tracked by Wall St. Rank hold STE as of Q2 2026.

Oppenheimer & Co reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
Oppenheimer & Co sold 974 Steris shares in Q2 2026, an estimated $215K.
Oppenheimer & Co first reported a position in Steris in Q2 2019 and held it in 4 quarters.
Oppenheimer & Co's Steris position peaked at $306K in Q2 2019.
837 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.